This report aims to provide a comprehensive presentation of the global market for Autoimmune Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Therapeutics Drugs. This report contains market size and forecasts of Autoimmune Therapeutics Drugs in global, including the following market information:
Global Autoimmune Therapeutics Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Autoimmune Therapeutics Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
NSAIDs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autoimmune Therapeutics Drugs include AbbVie, Amgen, Novartis, Eli Lilly and Company, Pfizer, Roche Holding AG, AstraZeneca, Abbott Laboratories and Genentech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Autoimmune Therapeutics Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autoimmune Therapeutics Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Autoimmune Therapeutics Drugs Market Segment Percentages, by Type, 2022 (%)
NSAIDs
Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs
Monoclonal Antibodies
Global Autoimmune Therapeutics Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Autoimmune Therapeutics Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
Global Autoimmune Therapeutics Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Autoimmune Therapeutics Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autoimmune Therapeutics Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autoimmune Therapeutics Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Novartis
Eli Lilly and Company
Pfizer
Roche Holding AG
AstraZeneca
Abbott Laboratories
Genentech
Merck & Co.
Bayer
Biogen
GlaxoSmithKline
Perrigo
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autoimmune Therapeutics Drugs, market overview.
Chapter 2: Global Autoimmune Therapeutics Drugs market size in revenue.
Chapter 3: Detailed analysis of Autoimmune Therapeutics Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autoimmune Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Autoimmune Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autoimmune Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autoimmune Therapeutics Drugs Overall Market Size
2.1 Global Autoimmune Therapeutics Drugs Market Size: 2022 VS 2032
2.2 Global Autoimmune Therapeutics Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Autoimmune Therapeutics Drugs Players in Global Market
3.2 Top Global Autoimmune Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Autoimmune Therapeutics Drugs Revenue by Companies
3.4 Top 3 and Top 5 Autoimmune Therapeutics Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Autoimmune Therapeutics Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autoimmune Therapeutics Drugs Players in Global Market
3.6.1 List of Global Tier 1 Autoimmune Therapeutics Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Autoimmune Therapeutics Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Autoimmune Therapeutics Drugs Market Size Markets, 2022 & 2032
4.1.2 NSAIDs
4.1.3 Corticosteroids
4.1.4 Disease-Modifying Anti-Rheumatic Drugs
4.1.5 Monoclonal Antibodies
4.2 By Type - Global Autoimmune Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Autoimmune Therapeutics Drugs Revenue, 2018-2023
4.2.2 By Type - Global Autoimmune Therapeutics Drugs Revenue, 2024-2032
4.2.3 By Type - Global Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Autoimmune Therapeutics Drugs Market Size, 2022 & 2032
5.1.2 Hospitals and Clinics
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Autoimmune Therapeutics Drugs Revenue & Forecasts
5.2.1 By Application - Global Autoimmune Therapeutics Drugs Revenue, 2018-2023
5.2.2 By Application - Global Autoimmune Therapeutics Drugs Revenue, 2024-2032
5.2.3 By Application - Global Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Autoimmune Therapeutics Drugs Market Size, 2022 & 2032
6.2 By Region - Global Autoimmune Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Autoimmune Therapeutics Drugs Revenue, 2018-2023
6.2.2 By Region - Global Autoimmune Therapeutics Drugs Revenue, 2024-2032
6.2.3 By Region - Global Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Autoimmune Therapeutics Drugs Revenue, 2018-2032
6.3.2 US Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.3.3 Canada Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.3.4 Mexico Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Autoimmune Therapeutics Drugs Revenue, 2018-2032
6.4.2 Germany Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.4.3 France Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.4.4 U.K. Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.4.5 Italy Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.4.6 Russia Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.4.8 Benelux Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Autoimmune Therapeutics Drugs Revenue, 2018-2032
6.5.2 China Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.5.3 Japan Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.5.4 South Korea Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.5.6 India Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Autoimmune Therapeutics Drugs Revenue, 2018-2032
6.6.2 Brazil Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.6.3 Argentina Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Autoimmune Therapeutics Drugs Revenue, 2018-2032
6.7.2 Turkey Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.7.3 Israel Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Autoimmune Therapeutics Drugs Market Size, 2018-2032
6.7.5 UAE Autoimmune Therapeutics Drugs Market Size, 2018-2032
7 Autoimmune Therapeutics Drugs Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Autoimmune Therapeutics Drugs Major Product Offerings
7.1.4 AbbVie Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Autoimmune Therapeutics Drugs Major Product Offerings
7.2.4 Amgen Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Autoimmune Therapeutics Drugs Major Product Offerings
7.3.4 Novartis Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Autoimmune Therapeutics Drugs Major Product Offerings
7.4.4 Eli Lilly and Company Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly and Company Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Autoimmune Therapeutics Drugs Major Product Offerings
7.5.4 Pfizer Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Roche Holding AG
7.6.1 Roche Holding AG Company Summary
7.6.2 Roche Holding AG Business Overview
7.6.3 Roche Holding AG Autoimmune Therapeutics Drugs Major Product Offerings
7.6.4 Roche Holding AG Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.6.5 Roche Holding AG Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Autoimmune Therapeutics Drugs Major Product Offerings
7.7.4 AstraZeneca Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Summary
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Autoimmune Therapeutics Drugs Major Product Offerings
7.8.4 Abbott Laboratories Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.8.5 Abbott Laboratories Key News & Latest Developments
7.9 Genentech
7.9.1 Genentech Company Summary
7.9.2 Genentech Business Overview
7.9.3 Genentech Autoimmune Therapeutics Drugs Major Product Offerings
7.9.4 Genentech Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.9.5 Genentech Key News & Latest Developments
7.10 Merck & Co.
7.10.1 Merck & Co. Company Summary
7.10.2 Merck & Co. Business Overview
7.10.3 Merck & Co. Autoimmune Therapeutics Drugs Major Product Offerings
7.10.4 Merck & Co. Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.10.5 Merck & Co. Key News & Latest Developments
7.11 Bayer
7.11.1 Bayer Company Summary
7.11.2 Bayer Business Overview
7.11.3 Bayer Autoimmune Therapeutics Drugs Major Product Offerings
7.11.4 Bayer Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.11.5 Bayer Key News & Latest Developments
7.12 Biogen
7.12.1 Biogen Company Summary
7.12.2 Biogen Business Overview
7.12.3 Biogen Autoimmune Therapeutics Drugs Major Product Offerings
7.12.4 Biogen Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.12.5 Biogen Key News & Latest Developments
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Company Summary
7.13.2 GlaxoSmithKline Business Overview
7.13.3 GlaxoSmithKline Autoimmune Therapeutics Drugs Major Product Offerings
7.13.4 GlaxoSmithKline Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.13.5 GlaxoSmithKline Key News & Latest Developments
7.14 Perrigo
7.14.1 Perrigo Company Summary
7.14.2 Perrigo Business Overview
7.14.3 Perrigo Autoimmune Therapeutics Drugs Major Product Offerings
7.14.4 Perrigo Autoimmune Therapeutics Drugs Revenue in Global Market (2018-2023)
7.14.5 Perrigo Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Autoimmune Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 2. Autoimmune Therapeutics Drugs Market Drivers in Global Market
Table 3. Autoimmune Therapeutics Drugs Market Restraints in Global Market
Table 4. Key Players of Autoimmune Therapeutics Drugs in Global Market
Table 5. Top Autoimmune Therapeutics Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Autoimmune Therapeutics Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Autoimmune Therapeutics Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Autoimmune Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Autoimmune Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autoimmune Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Autoimmune Therapeutics Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Autoimmune Therapeutics Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Autoimmune Therapeutics Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Autoimmune Therapeutics Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Autoimmune Therapeutics Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Autoimmune Therapeutics Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2024-2032
Table 30. AbbVie Company Summary
Table 31. AbbVie Autoimmune Therapeutics Drugs Product Offerings
Table 32. AbbVie Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Autoimmune Therapeutics Drugs Product Offerings
Table 36. Amgen Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Autoimmune Therapeutics Drugs Product Offerings
Table 40. Novartis Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Eli Lilly and Company Company Summary
Table 43. Eli Lilly and Company Autoimmune Therapeutics Drugs Product Offerings
Table 44. Eli Lilly and Company Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Eli Lilly and Company Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Autoimmune Therapeutics Drugs Product Offerings
Table 48. Pfizer Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Roche Holding AG Company Summary
Table 51. Roche Holding AG Autoimmune Therapeutics Drugs Product Offerings
Table 52. Roche Holding AG Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Roche Holding AG Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Autoimmune Therapeutics Drugs Product Offerings
Table 56. AstraZeneca Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Abbott Laboratories Company Summary
Table 59. Abbott Laboratories Autoimmune Therapeutics Drugs Product Offerings
Table 60. Abbott Laboratories Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Abbott Laboratories Key News & Latest Developments
Table 62. Genentech Company Summary
Table 63. Genentech Autoimmune Therapeutics Drugs Product Offerings
Table 64. Genentech Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Genentech Key News & Latest Developments
Table 66. Merck & Co. Company Summary
Table 67. Merck & Co. Autoimmune Therapeutics Drugs Product Offerings
Table 68. Merck & Co. Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Merck & Co. Key News & Latest Developments
Table 70. Bayer Company Summary
Table 71. Bayer Autoimmune Therapeutics Drugs Product Offerings
Table 72. Bayer Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Bayer Key News & Latest Developments
Table 74. Biogen Company Summary
Table 75. Biogen Autoimmune Therapeutics Drugs Product Offerings
Table 76. Biogen Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Biogen Key News & Latest Developments
Table 78. GlaxoSmithKline Company Summary
Table 79. GlaxoSmithKline Autoimmune Therapeutics Drugs Product Offerings
Table 80. GlaxoSmithKline Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. GlaxoSmithKline Key News & Latest Developments
Table 82. Perrigo Company Summary
Table 83. Perrigo Autoimmune Therapeutics Drugs Product Offerings
Table 84. Perrigo Autoimmune Therapeutics Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Perrigo Key News & Latest Developments
List of Figures
Figure 1. Autoimmune Therapeutics Drugs Segment by Type in 2022
Figure 2. Autoimmune Therapeutics Drugs Segment by Application in 2022
Figure 3. Global Autoimmune Therapeutics Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Autoimmune Therapeutics Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Autoimmune Therapeutics Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autoimmune Therapeutics Drugs Revenue in 2022
Figure 8. By Type - Global Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 16. US Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 28. China Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Autoimmune Therapeutics Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Autoimmune Therapeutics Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. AbbVie Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eli Lilly and Company Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roche Holding AG Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Abbott Laboratories Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Genentech Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck & Co. Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bayer Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Biogen Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. GlaxoSmithKline Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Perrigo Autoimmune Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
